Grant Details

GRANT OVERVIEW

Grant name and funding organization

New Investigator Gateway Awards for Collaborative T1D Research

National Institutes of Health (NIH)

Total funding amount and duration

Estimated funding amount: $100,000 per award

Maximum project duration: 2 years

Primary objective and mission statement

To support innovative projects and new investigators in T1D research.

To enhance collaboration within established research networks.

Key stakeholders and beneficiaries

New and Early Stage Investigators in T1D research.

Collaborative research networks and consortia.

ELIGIBILITY CRITERIA

Organization Requirements

Eligible organization types include higher education institutions, nonprofits, for-profit organizations, and government entities.

Non-domestic entities (foreign organizations) are not eligible to apply.

Geographic Scope

Only U.S.-based organizations are eligible.

Non-domestic components of U.S. organizations are not eligible.

Project Requirements

Research must focus on Type 1 Diabetes (T1D) and align with the goals of established consortia.

Projects should address significant barriers in T1D research.

Financial Requirements

Applications may request budgets of up to $100,000 in direct costs per year.

No cost-sharing is required.

Timeline Requirements

Application due date: March 6, 2026.

Earliest start date for funded projects: June 26, 2025.

Previous Funding Considerations

Applicants may submit more than one application if each is scientifically distinct.

Duplicate applications under review at the same time are not accepted.

APPLICATION PROCESS

Required documentation and materials

Applications must include a proposed affiliation letter outlining the relationship with the chosen consortium.

Evaluation criteria and scoring system

Applications will be evaluated based on significance, innovation, rigor, feasibility, and expertise.

Review process and timeline

Applications will undergo scientific peer review and receive a written critique.

Selection criteria and priorities

Scientific and technical merit of the proposed project will be prioritized.

SPECIAL CONSIDERATIONS

Unique aspects or requirements

Only non-clinical trial applications are accepted.

Potential challenges or limitations

Non-domestic entities are excluded from eligibility.

Strategic alignment opportunities

Collaboration with established research networks is encouraged.

Competitive advantages or disadvantages

New and Early Stage Investigators have a unique opportunity to establish their careers.

KEY INSIGHTS AND RECOMMENDATIONS

Critical success factors

Strong alignment with the goals of T1D research consortia.

Common pitfalls to avoid

Submitting overlapping applications.

Strategic recommendations for applicants

Engage with existing research networks to enhance application quality.

Competitive positioning advice

Highlight innovative aspects of the proposed research.

Grant Details

type 1 diabetes t1d research biomedical research collaborative research healthcare innovation new investigator early stage investigator
New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
RFA-DK-26-009
NIH Grants
EDU NGO PUBLIC ENTERPRISE OTHER
US
RESEARCH_DEVELOPMENT
False
100000.00
100000.00
100000.00
USD
None
True
False
Advancing understanding and treatment of Type 1 Diabetes through innovative research.
Research findings that contribute to T1D knowledge and potential therapeutic strategies.
March 6, 2026, 10 p.m.
March 2026
Proposed Affiliation Letter, Application Forms as per NIH guidelines.
True
Overall impact score based on scientific merit.
Significance and innovation of the proposed research.
Rigor and feasibility of the proposed approach.
Potential impact on T1D research and treatment.
False
False
Grant
Compliance with NIH Grants Policy Statement.
Annual progress reports and final report upon project completion.
Payments based on milestones and reporting.
NIH Grants Policy Statement and applicable federal regulations.
None